Stephens Inc. AR grew its holdings in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 191.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 94,439 shares of the technology company's stock after buying an additional 61,992 shares during the quarter. Stephens Inc. AR owned about 0.47% of Simulations Plus worth $2,316,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the business. Fifth Third Bancorp lifted its holdings in shares of Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock valued at $36,000 after buying an additional 375 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Simulations Plus by 4.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company's stock worth $254,000 after purchasing an additional 380 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after purchasing an additional 427 shares during the last quarter. Pitcairn Co. raised its holdings in Simulations Plus by 10.8% during the fourth quarter. Pitcairn Co. now owns 7,310 shares of the technology company's stock worth $204,000 after purchasing an additional 711 shares during the last quarter. Finally, Barclays PLC raised its holdings in Simulations Plus by 2.7% during the fourth quarter. Barclays PLC now owns 29,229 shares of the technology company's stock worth $815,000 after purchasing an additional 756 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
SLP has been the subject of several research reports. JMP Securities reaffirmed a "market perform" rating on shares of Simulations Plus in a report on Wednesday, June 18th. KeyCorp downgraded Simulations Plus from an "overweight" rating to a "sector weight" rating in a research report on Tuesday. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Stephens lowered their price objective on Simulations Plus from $28.00 to $20.00 and set an "overweight" rating for the company in a research report on Tuesday. Finally, William Blair restated an "outperform" rating on shares of Simulations Plus in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $26.50.
Check Out Our Latest Stock Analysis on SLP
Simulations Plus Stock Performance
Shares of NASDAQ SLP traded up $0.04 during mid-day trading on Thursday, reaching $12.95. The company had a trading volume of 905,347 shares, compared to its average volume of 302,212. Simulations Plus, Inc. has a twelve month low of $12.64 and a twelve month high of $44.27. The stock has a market capitalization of $260.34 million, a PE ratio of -4.10 and a beta of 0.83. The stock's 50 day moving average is $23.80 and its 200-day moving average is $28.08.
Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its earnings results on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.26 by $0.19. The firm had revenue of $20.36 million for the quarter, compared to the consensus estimate of $22.83 million. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 10.65%. The business's quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.27 earnings per share. On average, sell-side analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.
Insider Activity
In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the completion of the sale, the director owned 3,344,157 shares in the company, valued at approximately $112,062,701.07. This trade represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 19.40% of the company's stock.
About Simulations Plus
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.